BSEM
Price
$11.94
Change
-$0.05 (-0.42%)
Updated
Jul 3 closing price
Capitalization
199.31M
50 days until earnings call
VICP
Price
$1.77
Change
+$0.50 (+39.37%)
Updated
Mar 24 closing price
Capitalization
57.3M
Interact to see
Advertisement

BSEM vs VICP

Header iconBSEM vs VICP Comparison
Open Charts BSEM vs VICPBanner chart's image
BioStem Technologies
Price$11.94
Change-$0.05 (-0.42%)
Volume$28.03K
Capitalization199.31M
Vicapsys Life Sciences
Price$1.77
Change+$0.50 (+39.37%)
Volume$100
Capitalization57.3M
BSEM vs VICP Comparison Chart in %
Loading...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSEM vs. VICP commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSEM is a Hold and VICP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BSEM: $11.94 vs. VICP: $1.77)
Brand notoriety: BSEM and VICP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSEM: 50% vs. VICP: 100%
Market capitalization -- BSEM: $199.31M vs. VICP: $57.3M
BSEM [@Biotechnology] is valued at $199.31M. VICP’s [@Biotechnology] market capitalization is $57.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSEM’s FA Score shows that 0 FA rating(s) are green whileVICP’s FA Score has 1 green FA rating(s).

  • BSEM’s FA Score: 0 green, 5 red.
  • VICP’s FA Score: 1 green, 4 red.
According to our system of comparison, BSEM is a better buy in the long-term than VICP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSEM’s TA Score shows that 2 TA indicator(s) are bullish.

  • BSEM’s TA Score: 2 bullish, 6 bearish.

Price Growth

BSEM (@Biotechnology) experienced а -10.73% price change this week, while VICP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BSEM is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSEM($199M) has a higher market cap than VICP($57.3M). BSEM YTD gains are higher at: -13.728 vs. VICP (-74.714).
BSEMVICPBSEM / VICP
Capitalization199M57.3M347%
EBITDAN/AN/A-
Gain YTD-13.728-74.71418%
P/E Ratio8.12N/A-
RevenueN/AN/A-
Total Cash110KN/A-
Total Debt6.02MN/A-
FUNDAMENTALS RATINGS
BSEM vs VICP: Fundamental Ratings
BSEM
VICP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4989
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VICP's Valuation (1) in the null industry is somewhat better than the same rating for BSEM (56). This means that VICP’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for VICP (100). This means that BSEM’s stock grew somewhat faster than VICP’s over the last 12 months.

BSEM's SMR Rating (100) in the null industry is in the same range as VICP (100). This means that BSEM’s stock grew similarly to VICP’s over the last 12 months.

BSEM's Price Growth Rating (49) in the null industry is somewhat better than the same rating for VICP (89). This means that BSEM’s stock grew somewhat faster than VICP’s over the last 12 months.

BSEM's P/E Growth Rating (70) in the null industry is in the same range as VICP (100). This means that BSEM’s stock grew similarly to VICP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSEMVICP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
18%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
16%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGCX43.020.38
+0.89%
MFS Core Equity C
GLOSX22.450.15
+0.67%
Victory Pioneer Global Equity A
GLPIX37.910.04
+0.11%
Goldman Sachs MLP Energy Infras Inv
IGNYX17.30-0.02
-0.12%
Macquarie Natural Resources Y
HNRGX28.34-0.05
-0.18%
Hennessy Energy Transition Investor

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VICP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VICP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
-0.42%
VICP - BSEM
23%
Poorly correlated
N/A
BMNDF - BSEM
11%
Poorly correlated
N/A
BVNRY - BSEM
9%
Poorly correlated
+0.11%
BIXT - BSEM
6%
Poorly correlated
+1.88%
CMVLF - BSEM
5%
Poorly correlated
N/A
More

VICP and

Correlation & Price change

A.I.dvisor indicates that over the last year, VICP has been loosely correlated with DMAC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VICP jumps, then DMAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VICP
1D Price
Change %
VICP100%
N/A
DMAC - VICP
33%
Loosely correlated
+5.32%
GOVX - VICP
31%
Poorly correlated
+0.69%
KALA - VICP
29%
Poorly correlated
+0.99%
CASI - VICP
29%
Poorly correlated
-2.28%
ZLDPF - VICP
28%
Poorly correlated
N/A
More